Cyclin-dependent kinase 6 (CDK6) plays key roles in lung cancer cell proliferation and apoptosis, as well as being a candidate prognostic biomarker for non-small cell lung cancer (37–40). Here, CDK6 is linked to non-small cell lung carcinoma.